Pines Wealth Management, LLC Astrazeneca PLC Transaction History
Pines Wealth Management, LLC
- $297 Billion
- Q3 2025
A detailed history of Pines Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pines Wealth Management, LLC holds 5,638 shares of AZN stock, worth $504,037. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,638
Previous 6,267
10.04%
Holding current value
$504,037
Previous $435 Million
0.62%
% of portfolio
0.15%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...